Astrana Health
ASTH
37 hedge funds and large institutions have $43.7M invested in Astrana Health in 2019 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 14 increasing their positions, 11 reducing their positions, and 5 closing their positions.
27% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 11
0.39% less ownership
Funds ownership: 7.06% → 6.67% (-0.39%)
5% less funds holding
Funds holding: 39 → 37 (-2)
8% less capital invested
Capital invested by funds: $47.8M → $43.7M (-$4.04M)
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.87M |
| 2 |
MF
Manchester Financial
Westlake Village,
California
|
+$277K |
| 3 |
BlackRock
New York
|
+$252K |
| 4 |
ECM
ExodusPoint Capital Management
New York
|
+$218K |
| 5 |
Barclays
London,
United Kingdom
|
+$146K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Cadence Capital Management
Boston,
Massachusetts
|
-$1.58M |
| 2 |
RA
Royce & Associates
New York
|
-$808K |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$467K |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$338K |
| 5 |
Goldman Sachs
New York
|
-$273K |
ASTH Hedge Fund Activity: Q1 2019 in Review
37 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Astrana Health (ASTH) for Q1 2019, worth a combined $43.7M — down 8.5% from $47.8M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of ASTH and 3 opened new positions — a net loss of 2 holders — while 11 trimmed existing stakes and 14 added.
The largest buyer was Vanguard Group, adding an estimated $1.87M. The largest seller was Cadence Capital Management, exiting entirely with an estimated $1.58M sold.
- 37 institutional investors held Astrana Health (ASTH) as of Q1 2019, down from 39 in Q4 2018.
- Funds reported $43.7M of Astrana Health stock for Q1 2019, down 8.5% quarter-over-quarter.
- 3 funds opened new Astrana Health positions in Q1 2019 and 5 closed out, a net change of -2 holders.
- The largest Astrana Health buyer in Q1 2019 was Vanguard Group, an estimated $1.87M added.
- The largest Astrana Health seller in Q1 2019 was Cadence Capital Management, an estimated $1.58M sold.
Based on aggregated 13F filings for Q1 2019.